Pharmaceutical solution for oral dosage
AssigneesFtf Pharma Private Limited, Lm Manufacturing Ltd
InventorsSANDIP MEHTA, MANISH KUMAR UMRETHIA, JAYANTA MANDAL
Life of this patent
Estimating the term…
Abstract
This disclosure relates to pharmaceutical compositions in the form of a solution for oral delivery. Particularly, the pharmaceutical compositions comprise an active pharmaceutical ingredient, a buffering agent, and water. In some embodiments, the pH of the composition is from about pH 5 to about pH 8. In some embodiments, the active pharmaceutical ingredient is selected from ramipril, solifenacin, vigabatrin, losartan potassium, warfarin, and melatonin.
Claims9
A pharmaceutical composition comprising an active pharmaceutical ingredient, a buffering agent, and water, wherein the active pharmaceutical ingredient is present in the composition from about 0.1 wt % to about 20 wt %, and wherein pH of the composition is from about pH 5 to about pH 8.
A pharmaceutical composition comprising:
- an active pharmaceutical ingredient at about 10 wt %;
- a preservative from about 0.001 wt % to about 1 wt %;
- a buffering agent from about 0.001 wt % to about 1 wt %;
- a sweetener at about 20 wt %;
- a flavoring agent;
- water;
- and
- wherein a pH of the composition is from about pH 5 to about pH 8.
A method of treating a disease or disorder in a subject in need thereof, the method comprising administering a pharmaceutical composition comprising an active pharmaceutical ingredient, a buffering agent, and water, and wherein the active pharmaceutical ingredient is present in the composition from about 1 wt % to about 20 wt %, and wherein pH of the composition is from about pH 5 to about pH 8.
Dependencies are inferred from the claim text.